Posted on Apr 8, 2021, 10:10 a.m.
If the Griffuel Prize, which the ARC Foundation has just awarded to three exceptional researchers, is recognized as one of the most prestigious European awards in the field of oncology, we rarely know that it has been owed since 1970 to generosity. by Léopold and Alice Griffuel, a couple of philanthropists.
It allows the Arc Foundation to allocate 300,000 euros each year to researchers – sometimes nobel Prize winners – who advance science and improve the therapeutic care of patients. This year, the philanthropic structure selected Canadian, German and Japanese laureates, bringing the number of scientists awarded to date to 61, of 14 nationalities.
The Prize is financed by rents from two Parisian buildings bequeathed by the Griffuel couple. Because alongside donations, bequests and life insurance represent almost half of the resources of the Arc Foundation, one of the most active in the fight against a scourge which is the leading cause of death in France.
A major health issue. “Yet the research budget is derisory: 180 million euros, more than 40% of which is provided by the charitable world, against nearly $ 6 billion in public-private money in the United States” deplores the president of the Arc Foundation, Claude Tendil. While 400,000 people are affected each year, and 4 million cancers will occur within ten years, the goal is to help cure 2 out of 3 by 2025.
“The Arc Foundation collects approximately 40 million euros per year from 160,000 donors. These funds were down 7% last year, it is not catastrophic but it is worrying. And out of this envelope, 30 million go to research, of which the current health crisis reminds us of the fundamental role ” insiste Claude Tendil.
Since 2010, the Foundation has allocated nearly 300 million euros to more than 3,200 projects, focusing on the links between environment and cancer, access to targeted therapies and immunotherapies, prevention of recurrence, acceleration of cancer. oncopediatrics, hosting researchers, creating synergies in research at a global level …
Impact of Covid-19
“The results are there: cancer mortality has decreased by 2.0% per year in men and 0.7% per year in women between 2010 and 2018. But we must go further” pointe Claude Tendil.
The ARC Foundation can rely on the international vision provided by its steering committee and committee of independent experts, to identify priority issues in fundamental and applied research.
Each year, it offers researchers – at the start of their careers or more experienced – a grant of 25,000 euros for one or two years, in order to launch projects at an early stage, likely to generate research on a larger scale. More than 400 funding requests are studied by the Foundation’s volunteer expert committees and the board of directors retains more than a hundred per year.
Among the fields in which the association has been particularly invested are personalized medicine (because there are as many cancers as there are patients), the diagnosis of pancreatic cancer coupling echo endoscopy to artificial intelligence (3rd cause of cancer mortality and probably second by 2030-2040), and senior cancer with a large clinical program.
“The Arc Foundation has just invested 500,000 euros to carry out studies on the consequences of Covid-19 on cancer. Later, we will also measure the impact of the delays in treatment generated by the pandemic for cancer patients ” promet Claude Tendil.
LCL grants 500,000 euros to the Institut Pasteur de Lille
On Wednesday April 7, on the occasion of World Health Day, LCL and the Institut Pasteur de Lille signed a sponsorship agreement dedicated to the issue of health prevention and aging well. Through a donation of 500,000 euros, the bank is working alongside the Institute to develop prevention programs on the national territory intended to protect its health capital throughout life. This partnership will result in the creation of courses in two new regional metropolises by 2022 after the success of the Lille experiment, and beyond by that of a national network dedicated to longevity.
Get the latest news delivered to your inbox
Follow us on social media networks